Latex enhanced immunoturbidimetry kit for detection of asymmetric dimethylarginine content

A dimethylarginine and latex-enhanced technology, which is applied in the field of latex-enhanced immunoturbidimetric assay kits for detection of asymmetric dimethylarginine content, can solve the problems of long time-consuming, manual operation, cumbersome sample processing, etc. problem, to achieve high correlation, fast detection speed, and strong detection specificity

Active Publication Date: 2012-08-08
BEIJING STRONG BIOTECH INC
View PDF8 Cites 41 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Not only that, the above methods for detecting ADMA all have the charac...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Latex enhanced immunoturbidimetry kit for detection of asymmetric dimethylarginine content
  • Latex enhanced immunoturbidimetry kit for detection of asymmetric dimethylarginine content
  • Latex enhanced immunoturbidimetry kit for detection of asymmetric dimethylarginine content

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Example 1: Preparation of human serum albumin coupled to asymmetric dimethylarginine

[0044] Dilute 10mg of human serum albumin with 1mL of 0.1M phosphate buffer (pH7.8), add asymmetric dimethylarginine, then add 50mg of EDAC, react at 4°C for 24 hours, and then add 0.1M phosphate The buffer solution (pH7.8) was dialyzed at 4°C for 24 hours to prepare ADMA-coupled human serum albumin (asymmetric dimethylarginine-human serum albumin complex).

Embodiment 2

[0045] Embodiment 2: Preparation of asymmetric dimethylarginine R2 reagent

[0046] Carboxyl groups on the surface, polystyrene latex solution (concentration 10%) (purchased from Merck) 150nm in diameter 0.5mL, add 4.5mL of 0.05M MES buffer (pH6.0), then add 5mg EDAC, react at 37 ° C 1 hour. After diluting 0.5 mg of human serum albumin coupled with ADMA with 5 mL of 0.05 M borate buffer (pH 9.2), it was immediately added to the above latex solution and reacted at 37° C. for 6 hours. Finally, add 1mL of 0.1M glycine buffer (pH8.5) and stir for 1h to stop the reaction, centrifuge to remove the supernatant, wash 3 times with 20mL of 50mM glycine buffer (pH8.0), 50mM glycine buffer contains 0.9% Sodium chloride, 20mM EDTA, 0.8% BSA, 0.1% Tween 20, 0.1% sodium azide, and finally disperse into a milky white latex suspension with the same 20mL glycine buffer solution, which is the R2 reagent, and the final R2 reagent is asymmetric The concentration of polystyrene latex particles co...

Embodiment 3

[0047] Example 3: Preparation of asymmetric dimethylarginine R1 reagent

[0048] In 50mM Tris-HCl buffer at pH7.2, add 0.2mg / mL of ADMA monoclonal antibody (purchased from Abcam), and add sodium chloride 0.9%, PEG-60005%, BSA 0.2%, EDTA20mM, azide Sodium chloride 0.1%, stir evenly to be R1 reagent.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Login to view more

Abstract

The invention relates to a latex enhanced immunoturbidimetry kit for the detection of asymmetric dimethylarginine content. Specifically, the invention relates to a latex enhanced immunoturbidimetry kit for the detection of asymmetric dimethylarginine (ADMA) content in human blood samples. The kit comprises a mouse anti-human monoclonal antibody solution, an ADMA-human Serum albumin complex crosslinked latex particle expansion and an ADMA calibrator. According to the method, by the utilization of competitive binding of free ADMA in blood and ADMA crosslinked on the surface of latex particles to ADMA monoclonal antibody, turbidity formed by the reaction between the ADMA-crosslinked latex particles and ADMA monoclonal antibody is reduced. Therefore, the content of ADMA is detected through the reduction degree of turbidity. The kit provided by the invention can be applied in a biochemical analyzer commonly-used in clinic, is convenient and rapid to operate and has strong specificity. Both sensitivity and detection range of the kit can satisfy clinic application needs.

Description

technical field [0001] The invention provides a kit for determining the content of asymmetric dimethylarginine in human serum and plasma samples by using an immunoturbidimetric method, and specifically relates to the use of asymmetric dimethylarginine and cross-linked asymmetric dimethylarginine in human serum and plasma samples. Latex suspension linked with asymmetric dimethylarginine-human serum albumin complex competes for the binding of mouse anti-asymmetric dimethylarginine monoclonal antibody, and achieves high sensitivity by detecting the decrease of immune turbidity And a wider detection range, belonging to the field of medical immune in vitro diagnosis. Background technique [0002] Asymmetric dimethylarginine (ADMA) is a natural amino acid widely present in tissues and cells. It can inhibit the synthesis of nitric oxide synthase (NOS) and the resulting biological effects, prevent the synthesis of nitric oxide (NO) in endothelial cells, and lead to the decrease of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/68G01N33/564
CPCG01N33/543G01N33/585
Inventor 高爱民蔡华雅刘希
Owner BEIJING STRONG BIOTECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap